- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED May 03, 2024
Companys with strong funding and high growth potential
84 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BOVN.F | kr4.70 | 0% | n/a | kr2.7b | kr12.58 | PS9.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.75 | 2.7% | -46.5% | US$225.0m | US$25.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | Pharmaceuticals & Biotech | ||
AVH | US$2.66 | 1.5% | -43.9% | US$225.0m | US$7.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
0ABW | kr5.94 | 0% | -26.7% | kr2.0b | kr11.20 | PS35.4x | E86.9% | n/a | Pharmaceuticals & Biotech | ||
AVH | US$2.67 | 1.9% | -43.9% | US$225.0m | US$7.93 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
AVHH.L | US$1.53 | 0% | n/a | US$225.0m | US$4.53 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
IPHY.F | €2.13 | -19.6% | -26.3% | €178.3m | €6.06 | PS2.9x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
ARDX | US$8.70 | 35.4% | 88.6% | US$1.6b | US$13.39 | PS12.8x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
0EVI | €2.20 | -2.0% | -18.7% | €178.3m | €6.26 | PS2.9x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
IPHA | €2.55 | 3.5% | -15.2% | €178.3m | €7.24 | PS2.9x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
IVBI.Y | HK$19.48 | 0% | n/a | HK$67.9b | HK$26.28 | PS9.9x | E51.4% | n/a | Pharmaceuticals & Biotech | ||
CSPH.F | HK$0.12 | 0% | n/a | HK$1.4b | n/a | PS2.8x | E56.9% | n/a | Pharmaceuticals & Biotech | ||
MSB | AU$1.09 | 17.2% | 13.0% | AU$1.2b | AU$1.11 | PS109.2x | E56.8% | n/a | Pharmaceuticals & Biotech | ||
0JDK | US$13.44 | 14.6% | 97.3% | US$3.6b | US$25.63 | PS3207.8x | E61.7% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$229.84 | 18.9% | -25.0% | US$4.6b | US$377.07 | PB12.1x | E61.4% | n/a | Pharmaceuticals & Biotech | ||
CAPR | US$5.47 | 1.1% | 39.5% | US$165.1m | US$21.00 | PS6.8x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
ACAD | US$17.05 | 2.0% | -22.3% | US$2.8b | US$28.75 | PS3.9x | E40.8% | n/a | Pharmaceuticals & Biotech | ||
SPRY | US$9.75 | 16.8% | 54.5% | US$916.6m | US$19.00 | PS31490.7x | E56.2% | n/a | Pharmaceuticals & Biotech | ||
ALDX | US$4.16 | 5.9% | -60.6% | US$250.1m | US$9.25 | PB2.2x | E60.5% | n/a | Pharmaceuticals & Biotech |